Eisai
4523.T
#2229
Rank
โ‚น846.61 B
Marketcap
โ‚น3,000
Share price
-0.46%
Change (1 day)
-2.91%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น83.00. In 2026 the company made an earnings per share (EPS) of โ‚น82.64 a decrease over its 2025 EPS that were of โ‚น104.66.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026โ‚น82.64-21.04%
2025โ‚น104.6611.85%
2024โ‚น93.57-32.63%
2023โ‚น138.895.52%
2022โ‚น131.63-74.01%
2021โ‚น506.40-66.58%
2020โ‚น1,51598.24%
2019โ‚น764.2417.01%
2018โ‚น653.1337.78%
2017โ‚น474.05-27.62%
2016โ‚น654.9635.33%
2015โ‚น483.98-2.82%
2014โ‚น498.03-27.66%
2013โ‚น688.50-27.49%
2012โ‚น949.57-12.67%
2011โ‚น1,08788.08%
2010โ‚น578.15-11.06%
2009โ‚น650.06-390.15%
2008-โ‚น224.05-127.78%
2007โ‚น806.61347.11%
2006โ‚น180.404.38%
2005โ‚น172.847.4%
2004โ‚น160.9443.03%
2003โ‚น112.5325.09%
2002โ‚น89.9552.67%
2001โ‚น58.9269.76%
2000โ‚น34.71